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Abstract: RNA is a ubiquitous biopolymer that performs a multitude of essential cellular functions
involving the maintenance, transfer, and processing of genetic information. RNA is unique in that
it can carry both genetic information and catalytic function. Its secondary structure domains, which
fold stably and independently, assemble hierarchically into modular tertiary structures. Studies of
these folding events are key to understanding how catalytic RNAs (ribozymes) are able to position
reaction components for site-specific chemistry. We have made use of fluorescence techniques to
monitor the rates and free energies of folding of the small hairpin and hepatitis delta virus (HDV)
ribozymes, found in satellite RNAs of plant and the human hepatitis B viruses, respectively. In
particular, fluorescence resonance energy transfer (FRET) has been employed to monitor global
conformational changes, and 2-aminopurine fluorescence quenching to probe for local structural
rearrangements. In this review we illuminate what we have learned about the reaction pathways of
the hairpin and HDV ribozymes, and how our results have complemented other biochemical and
biophysical investigations. The structural transitions observed in these two small catalytic RNAs are
likely to be found in many other biological RNAs, and the described fluorescence techniques promise
to be broadly applicable. © 2002 Wiley Periodicals, Inc. Biopoly (Nucleic Acid Sci) 61:
224–241, 2002
Keywords: fluorescence quenching; fluorescence resonance energy transfer; folding free energy
landscape; ribozyme; RNA folding kinetics
INTRODUCTION
Nature uses fundamental principles of organic and
physical chemistry to generate self-replicating and
evolving biopolymers that make up life as we know it.
In this respect, RNA is a particularly well-suited
biopolymer with a unique ability to carry both genetic
information and catalytic function. It plays a key role
in all aspects of the maintenance, transfer, and pro-
cessing of genetic information, in the form of mes-
senger, transfer, ribosomal, spliceosomal RNAs, and
viral RNA genomes. According to the RNA World
hypothesis, it may even have initiated life on earth.1
Only recently, we have begun to discover some of the
reasons for this central function. First, RNA serves a
role in the coding and decoding of genetic information
through specific Watson–Crick base pairing (second-
ary structure). Second, RNA forms catalytically active
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components of the gene processing machinery
through folding into intricate tertiary structures with
precisely positioned unpaired nucleobases. Finally,
RNA can undergo substantial conformational changes
in the course of a reaction pathway without the need
for an external energy source through its intrinsic
structural dynamics. In the extreme, the same RNA
sequence may fold into two entirely different second-
ary and tertiary structures with distinct catalytic ac-
tivities.2
The number of confirmed naturally occurring cat-
alytic RNAs, or ribozymes, is continuously on the
rise. The most recent count includes the ribosomal
RNAs of the protein biosynthetic machinery3 and the
small nuclear RNAs of the eukaryotic splicing ma-
chinery.4 For these large ribonucleoprotein com-
plexes, activity of the RNA in the absence of protein
components is slow and rudimentary,4,5 yet undoubt-
edly the RNA carries the functional components for
catalysis. The role of the proteins seems to be limited
to helping align RNA catalytic core components and
substrates, and to timing the multitude of conforma-
tional rearrangements that lead to a full catalytic cy-
cle.6,7
Even including the most recent recruits among the
naturally occurring ribozymes, their organic chemis-
try repertoire is limited to nucleophilic substitutions
on phospho or carboxyl esters, either with internal
(“cis”) or external (“trans”) substrates. This limita-
tion contrasts with the multitude of catalytic functions
of protein enzymes. It is at least in part imposed by
the limited diversity of functional groups on the four
basic nucleotide building blocks of RNA, compared
to the twenty amino acids of proteins. This restriction
in chemical capacity has been partially lifted by arti-
ficial in vitro selection of ribozymes with activities
such as glycosidic bond hydrolysis and Diels–Alder
cycloaddition, but for a still broader catalytic range
the incorporation of additional functional moieties
appears necessary.8 Interestingly, there is no evidence
that nature has expanded its catalytic repertoire by
making use of the 95 modified nucleosides known to
occur in natural RNA.9,10 In recent years it has be-
come clear that, by precisely positioning the nucleo-
bases A, U, G, and C, and other reaction components
in the catalytic core, RNA can lower the activation
barrier for site-specific chemistry by employing metal
ion catalysis, general acid–base catalysis by nucleo-
bases with electrostatically modulated pKa, and intrin-
sic substrate binding energy.11,12
The catalytic repertoire of the subclass of four
naturally occurring small ribozymes is restricted to
the same reversible phosphodiester transfer reaction
that occurs spontaneously in base-catalyzed chemical
RNA degradation. Yet the hammerhead, hairpin, hep-
atitis delta virus (HDV), and Neurospora Varkud sat-
ellite (VS) ribozymes accelerate this reaction by six to
seven orders of magnitude and lend it site specificity,
which characterizes them as true catalysts. All four
ribozymes were isolated from small self-replicating
satellite RNAs. They are assumed to play a crucial
role in the double-rolling circle replication of these
satellite RNAs, acting as a site-specific endonuclease
and ligase in different stages of replication. In case of
the hammerhead, hairpin, and HDV ribozymes, their
particularly small size (85 nucleotide (nt)) has en-
abled chemical synthesis and detailed structural and
enzymologic studies. We now have atomic-resolution
crystal structures available to provide a framework for
probing into their dynamics and function (for a recent
review, see Ref. 13). For the somewhat larger VS
ribozyme (160 nt), which so far has eluded crystalli-
zation attempts (R. Collins, personal communica-
tions), information on the location of the catalytic
core has recently emerged.14,15
Nature’s solutions to accomplish site-specific RNA
backbone cleavage are surprisingly diverse; that is,
the secondary and tertiary structures of the four small
ribozymes are very distinct from one another. This is
surprising since in vitro selection from an unbiased
random RNA pool nearly exclusively yields only the
simplest of these motifs, the hammerhead ribozyme.16
The reason for nature to choose among different,
more complex solutions may lie in specific require-
ments for the double-rolling circle replication of a
particular satellite RNA. For example, timing of
cleavage and ligation in different replication stages
may require regulated folding and unfolding of the
active structure; or requirements such as stability
against host cellular ribonucleases, compatibility with
viral packaging, or the necessity to have a catalyti-
cally active motif in both complementary strands may
impose specific sequence restrictions on the motifs to
be used in each satellite RNA.
By comparison to their limited organic chemistry
repertoire, ribozymes have started to amaze us with a
rich physical chemistry of folding into their functional
structures. The high thermodynamic stability of base
pairs (through both hydrogen bonding and base stack-
ing) provides the basis for folding of proximal, par-
tially self-complementary regions into domains with
secondary structure.17,18 Recent work has provided
evidence for a hierarchical assembly of these inde-
pendently and stably folded domains into larger mod-
ular RNA structures (reviewed in Refs. 19 and 20). To
accommodate distal tertiary interactions, local inter-
actions often have to be broken and rearranged. Such
processes can pose kinetic traps for folding into the
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functional (native) structure,21 providing for rugged
folding free energy landscapes.22,23 Studies of these
folding events are key to understanding how catalytic
RNAs are able to position reaction components so that
they are poised for site-specific chemistry.
We have made use of fluorescence techniques to
monitor the rates and free energies of folding of
several small catalytic RNAs into functional struc-
tures. Although these studies are certainly not limited
to catalytic RNA, ribozymes provide convenient
model systems as their catalytic function readily re-
ports the presence of a fully folded native structure. In
particular, we have studied the hairpin ribozyme, de-
rived from the negative strand of the tobacco ringspot
virus satellite RNA, and the HDV ribozyme found in
the human pathogen HDV. In this review we illumi-
nate what we have learned from these studies about
global and local conformational rearrangements along
the reaction pathway, and how our results have com-
plemented other biochemical and biophysical investi-
gations. We have organized the text by ribozyme, and
in both cases present data from steady-state fluores-
cence resonance energy transfer (FRET), time-re-
solved FRET, and 2-aminopurine fluorescence
quenching.
THE HAIRPIN RIBOZYME
The hairpin ribozyme is a small endonucleolytic
RNA motif of 50 nucleotides that has proven to
be an exciting model for RNA folding prob-
lems21,24 –29 as well as a promising gene therapeutic
agent for targeted RNA inactivation.29,30 From the
naturally occurring RNA four-way junction, it has
been engineered into a hinged two-way junction
that cleaves external substrates in trans immedi-
ately 5 of G1.27 This minimal ribozyme–sub-
strate complex consists of the two helix–loop– helix
domains A and B. A number of studies, including
those reviewed here, have revealed the multistep
reaction pathway shown in Figure 1a: (1) substrate
S binds to the ribozyme forming an extended and
inactive conformation, in which domains A and B
are coaxially stacked; (2) the complex folds into an
active docked conformation with the two domains
interacting side-by-side; (3) reversible cleavage oc-
curs; (4) the complex undocks and the cleavage
products dissociate or vice versa. High-resolution
NMR structures of the isolated domains A31 and
B32 have been determined, and their base pair in-
teractions are summarized in the extended confor-
mation of Figure 1a. Aside from the fluorescence
techniques outlined below, docking has been stud-
ied by hydroxyl-radical footprinting,26 interdomain
cross-linking,33–35 and molecular modeling.33,35,36
Regarding specific interactions between the two
domains in the docked structure, mutational analy-
ses have revealed a functionally crucial Watson–
Crick base pair between G1 of the substrate and
C25 of the ribozyme core.36 In a recent crystal
structure of the hairpin ribozyme,37 this base pair as
well as several additional hydrogen bonds, includ-
ing a ribose zipper motif first predicted by modifi-
cation interference38,39 and modeling studies,33
were identified as the network of contact points
responsible for domain docking (all summarized in
the docked conformation of Figure 1a). In the crys-
tal structure, G1 is inserted into a highly comple-
mentary binding pocket in domain B, highlighted in
Figure 1b. The accompanying base flipping of G1
generates the backbone in-line attack configuration
required for site-specific SN2-type phosphodiester
cleavage chemistry immediately 5 of G1. It has
been noted how nicely the crystallographic, bio-
chemical, and computational studies of the hairpin
ribozyme have complemented each other in corre-
lating structure and function.40
Studies of its metal ion dependence revealed a
fascinating feature of the hairpin ribozyme in that it
does not employ divalent metal ions as obligatory
catalytic components during reaction chemistry.41–43
This discovery ran contrary to previous belief in the
field,44 and sparked renewed interest in dissecting the
roles of metal ions in folding and function of small
catalytic RNAs. This enhanced interest led, in turn, to
the surprising finding that all small catalytic RNAs are
functional in monovalent cations alone,45–47 provid-
ing direct evidence that the RNAs themselves carry all
catalytic residues. To explain how a linear RNA chain
can form the scaffold that positions all these compo-
nents for catalytic function, probing into the folding
of its three-dimensional structure becomes particu-
larly important. In case of the hairpin ribozyme, flu-
orescence methods have turned out to be ideally
suited to probe into the kinetics and thermodynamics
of folding.
Domain Docking of the
Hairpin Ribozyme is Revealed by
Steady-State FRET
FRET, or Förster transfer,48 originates from the non-
radiative dipole–dipole interaction of two fluoro-
phores, called donor and acceptor, through space.49–59
The resulting strong dependence of the energy trans-
fer rate kT and hence the energy transfer efficiency ET
on the donor–acceptor distance R is expressed as
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FIGURE 1 Catalysis by the hairpin ribozyme. (a) Schematic of the minimal reaction pathway of
the hairpin ribozyme. Substrate (S) is bound by the ribozyme (Rz) to form an extended complex,
with helices 2 and 3 coaxially stacked. This inactive intermediate needs to bend around a flexible
hinge for loops A and B to interact in the docked, active conformation. For both the extended and
docked conformers we use a two-dimensional representation, annotated according to Ref. 85 with
their tertiary structures as suggested by NMR31,32 and x-ray crystallography,37 respectively; the
colored nucleotides and base-pair interaction are the ones detailed in (b). The cleaved docked
complex presumably partitions between re-ligation of the cleavage products and undocking. The
short 5 and 3 products (5P, 3P) then dissociate from the complex. (b) Details of the catalytic core.
G1 of the substrate is held in place by a Watson–Crick hydrogen-bonding interaction (dashed
tubes) with C25 of the ribozyme B domain (green ribbon, backbone), flipping the base so that an
in-line attack configuration is reached at the cleavage site (arrow). U2 unstacks from G1 as a
result of an induced fit upon domain docking. This figure was generated using the crystal structure37
and Swiss-PdbViewer 3.7.86













where D is the donor fluorescence lifetime in the
absence of acceptor and R0 is the Förster distance at
which ET is 50%. R0 is dependent on the spectral
overlap and the relative spatial orientation of the
utilized fluorophores, and typically has a value of
20–90 Å, which enables the measurement of fluoro-
phore distances in the range of 10–100 Å. When two
fluorophores are covalently tethered to defined sites
on a biopolymer, or on two molecules in a complex,
the distance between these sites can be measured. The
distance range accessible by FRET is ideal for many
biological macromolecules and fills the gap between
that of other techniques, such as NMR and cryo
electron microscopy (see also other articles in this
issue). In addition, changes in fluorophore distance
over a biopolymer folding time course can be moni-
tored in real time under a wide variety of buffer
conditions when continuously exciting the donor
(steady-state excitation).
To enable steady-state FRET (ss-FRET) measure-
ments between domains A and B of the hairpin ri-
bozyme, we have utilized a synthetically convenient
fluorescein–hexachlorofluorescein donor–acceptor
pair on the 3 and 5 ends, respectively, of the 5
segment of the ribozyme (Figure 1a) (for specifics on
labeling chemistry, see Refs. 24 and 58). We have
found that other donor–acceptor pairs such as fluores-
cein–tetramethylrhodamine or Cy3–Cy5 yield very
similar results. A 10-fold molar excess of the separate
3 segment is annealed to the 5 segment in standard
buffer (50 mM Tris HCl, pH 7.5, 12 mM MgCl2, 25
mM dithiothreitol (DTT), and at 25°C) to ensure that
the fluorescently labeled strand is quantitatively con-
verted into assembled ribozyme. The sequences of
ribozyme and substrate are optimized for rapid sub-
strate binding and efficient catalysis.
Upon mixing of the fluorophore-labeled ribozyme
with a 10-fold excess of cognate noncleavable sub-
strate analog S(2OMeA-1), in which the nucleophilic
2 OH group of A-1 is replaced by a 2 O-methyl
group to block the cleavage reaction, an instant ac-
ceptor quench and slight donor dequench are observed
(Figure 2).24 A concomitant fluorescence anisotropy
increase of the acceptor reveals the decreasing fluoro-
phore mobility upon substrate binding, which, under
the utilized conditions, is fast and occurs within the
manual mixing time.60 Noncognate substrates do not
lead to any of these changes. From these observations
we conclude that the instant fluorescence changes
upon cognate substrate addition are due to, first,
quenching of hexachlorofluorescein, and second, de-
creased FRET between donor and acceptor in the
extended conformation adopted by the ribozyme–sub-
strate complex.24
Subsequently, the donor fluorescence decreases
over several minutes, while the acceptor fluorescence
increases at the same rate (Figure 2). This observation
strongly suggests that the underlying molecular pro-
cess involves increasing FRET between the two flu-
orophores, as expected for their approach upon do-
main docking in the ribozyme–substrate complex (in-
set of Figure 2). From the temporal change of the ratio
Q  F560/F515, a relative measure of the FRET effi-
ciency, the rate constant of the transition between the
extended and docked conformations is extracted.24
For the reversible docking step of the noncleavable
substrate analog, the observed docking rate constant
kdock,obs of (0.84  0.04) min
1 is a combination of
the elementary docking and undocking rate constants:
kdock,obs  kdock  kundock (3)
The kdock,obs can only be further dissected by an
independent measurement of the docking equilibrium
constant or the undocking rate constant. A fraction of
61% docked ribozyme–substrate analog [S(2OMeA-
1)] complex, measured by time-resolved FRET (see
section on global geometry and equilibrium position
below),25 leads to estimates for kdock and kundock of 0.5
and 0.3 min1, respectively. A cleavable all-ribose
substrate with 2 hydroxyl group on A-1 yields very
similar rate constants when considering that the ob-
served docking rate constant kdock,obs of (1.02  0.07)
min1 also contains the rate of cleavage:
kdock,obs  kdock  kundock  kcleav (4)
The kcleav has a value of 0.14 min
1 under these
conditions. That makes docking into an active ri-
bozyme–substrate complex about 3.5 times faster than
cleavage and, therefore, only partially rate limiting.24
Interestingly, when A-1 is modified to 2 deoxy [in
the noncleavable substrate analog S(dA-1)], the ob-
served rate constant kdock,obs of (0.64  0.04) min
1
is slightly slower than with a 2 O-methyl or 2
hydroxyl. Perhaps this observation reflects the differ-
ent sugar pucker preference of 2 deoxy (C2-endo)
compared to either 2 O-methyl or 2 hydroxyl (C3-
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endo),61 or its lack of a hydrogen bond with G8,37
which may, in turn, impact the ability to promote base
flipping of the adjacent G1 as required for access to
the docked conformation.37
Strikingly, most modifications to the RNA se-
quence or reaction conditions that inhibit catalysis do
so by interfering with docking.24 For example, sub-
stitution of G1 with A, C, or U results in profound
inhibition of the reaction.62 Use of the G1A mutant
in the ss-FRET assay proves that the modified sub-
strate indeed binds to the substrate-binding strand, as
indicated by quenching of hexachlorofluorescein (see
above). However, no subsequent increase in FRET is
observed. Therefore, we can conclude that the mech-
anism of inhibition by a G1A substitution involves
blocking of the essential domain docking step, and not
direct interference with reaction chemistry as sug-
gested previously.62 When a compensatory mutation,
C25U, is introduced into domain B, catalytic activity
is restored to within 10-fold of wild-type activity,
although docking is still not observable.36 In general,
all Watson–Crick-type combinations between the sub-
strate 1 and ribozyme 25 positions show such a
behavior, which for the first time proved a function-
ally important interaction between these positions.
This crucial interaction was later confirmed in the
crystal structure of the hairpin ribozyme.37 In the
partially active double mutants, such as G1A/C25U,
domain docking is less stable and transient, as re-
cently observed by single-molecule FRET.87
For substrate variants with U2 substitutions that
result in a 70- to 13-fold reduced cleavage activity
domain, docking is generally stable.63 Interestingly,
the FRET signal increase clearly displays a second,
slower phase, a unique feature among all tested mod-
ifications of sequence or conditions.24 This second
phase leads to a higher overall amplitude of the FRET
increase that can be correlated with a higher abun-
dance of docked complex. This observation invokes a
mechanism of functional interference by a U2 mu-
tation in which the ribozyme–substrate complex be-
comes trapped in a native-like docked fold, proceed-
ing only slowly to the transition state63 (see also
section on local structural dynamics below). Recently,
similar evidence has been invoked to suggest a di-
rect catalytic role of G8 in reversible cleavage
chemistry.64
We further have used ss-FRET to compare domain
docking under a variety of ionic conditions. As ex-
pected, divalent metal ions that promote catalytic ac-
FIGURE 2 Analysis of the docking kinetics of the hairpin ribozyme–substrate complex by
ss-FRET. The doubly labeled ribozyme displays a strong signal for the acceptor fluorophore and a
weaker one for the donor. Upon manual addition of a tenfold excess of noncleavable substrate
analog [S(2OMeA-1)], significant quenching of the acceptor fluorescence is observed due to rapid
ribozyme–substrate complex formation. Subsequently, the acceptor signal increases, while the donor
signal decreases at the same rate, revealing the reversible docking kinetics from an extended to a
docked conformation (inset: green arrow, FRET; crossed-out arrow, substrate modification to render
it noncleavable). Standard conditions: 50 mM Tris HCl, pH 7.5, 12 mM MgCl2, at 25°C.
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tivity, such as Mg2, Ca2, or Sr2, lead to efficient
docking, the rate of which increases with the (milli-
molar) cation concentration.24 High (1M) concen-
trations of monovalent cations, such as Na, also
promote both docking and cleavage.45 These results
support the notion that metal ions are not obligatory
chemical participants in the reaction catalyzed by the
hairpin ribozyme, but rather assist and accelerate fold-
ing of the RNA into the active docked conformation
by neutralizing negative backbone charges.27 Based
on crystallographic and biochemical evidence, G8
and A38 have recently been proposed to then become
positioned to contribute the functional groups neces-
sary for general acid–base catalysis of reversible
cleavage.37,64
Our results demonstrate the versatility of ss-FRET
to directly monitor global RNA folding events in
solution under a variety of conditions and to derive
RNA folding kinetics. Analyses using time-resolved
FRET perfectly complement these data by providing
information on the relative stability and the structural
characteristics of the conformers involved.
Global Geometry and Equilibrium
Position of Domain Docking are Derived
from Time-Resolved FRET
While steady-state FRET enables detection of quali-
tative structural changes, it does not allow us to quan-
tify their magnitude. To measure absolute distances
between the fluorophores attached to the hairpin ri-
bozyme, we employed time-resolved FRET (tr-
FRET). Figure 3 shows the principle of these mea-
surements. The hairpin ribozyme is doubly labeled
with a donor (fluorescein) and an acceptor fluorophore
(tetramethylrhodamine) whose emission maxima are
well separated so that the donor emission can be
optically isolated. First, the time-resolved donor flu-
orescence decay in a donor-only labeled ribozyme–
substrate complex is measured. Then, the donor flu-
orescence decay in the donor–acceptor doubly labeled
complex is measured under identical conditions. The
faster decay in the doubly labeled ribozyme is due to
FRET from donor to acceptor; the closer the two
fluorophores are the shorter the donor fluorescence
lifetime. On the time scale of a typical donor fluoro-
phore lifetime in the excited state (nanoseconds),
large-scale molecular motions are slow and the do-
nor–acceptor distance appears fixed. Therefore, each
individual donor–acceptor distance will be character-
ized by a unique donor fluorescence lifetime. A flex-
ible molecule will display a distribution of donor–
acceptor distances that projects into a distribution of
donor lifetimes. If, as is the case for the hairpin
ribozyme, there are two distinct conformational iso-
mers in equilibrium, each one will contribute its spe-
cific donor lifetime distribution that can be discerned
in the overall fluorescence decay (Figure 3).25 The
principle of the tr-FRET method and details of the
instrumentation and data analysis are described in the
accompanying article by Klostermeier and Millar.
It is important to note that the single-photon count-
ing techniques used to obtain the high-precision decay
data require a significant acquisition time of tens of
minutes. Hence, only samples in thermodynamic
equilibrium can be studied. “Time-resolved” FRET
refers to the fact that fluorescence decay data are
measured, while the distance distribution(s) need to
remain constant over the data acquisition time. In
contrast, ss-FRET allows one to derive kinetic data
(see section immediately above).
Application of the tr-FRET methodology to the
wild-type hairpin ribozyme with bound S(dA-1) sub-
strate analog reveals two distinct lifetime and distance
distributions, corresponding to docked and extended
conformers (Figure 3). Thus, tr-FRET resolves the
equilibrium distribution between the two hairpin ri-
bozyme conformational isomers in solution (Figure
3). Under standard conditions, 65% of the wild-type
ribozyme–substrate analog [S(dA-1)] complex resides
in the active docked conformation with a mean do-
nor–acceptor distance of 34 Å (full-width-at-half-
maximum, fwhm, 18 Å), while 35% of the population
adopts the inactive extended conformation with a
mean distance of 78 Å (fwhm, 18 Å). In contrast, the
G1A mutant ribozyme–substrate complex is best
described by a single, extended conformation, as pre-
dicted by our ss-FRET experiments. It is important to
note that other methods that yield RNA structural
information, such as NMR, x-ray crystallography, or
chemical probing techniques, often fail to do so on
conformer mixtures. By contrast, tr-FRET extracts
mean distances between the donor–acceptor labeling
sites on the extended and docked hairpin ribozyme
conformers, useful for molecular modeling purposes,
and quantifies their relative abundance at equilibri-
um.25 The latter values define the equilibrium con-








Together with Eq. (3) and the kinetic data derived
from ss-FRET, the elementary docking and undock-
ing rate constants kdock and kundock are deduced (0.5
and 0.3 min1, respectively, see section immediately
above). In addition, the associated free energy differ-
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ence 	Gdock between the two structurally defined
minima in the folding free energy landscape of the
hairpin ribozyme is calculated from RT ln(Kdock)
to 0.34 kcal/mol.25 We find that mutations, changes
in metal ion concentration, and the nature of the
helical junction between domains A and B strongly
impact the equilibrium distribution between docked
and extended conformers.
For example, linking the wild-type substrate to the
ribozyme through a 6-nucleotide bulge additionally
stabilizes the docked conformer by 0.28 kcal/mol,25
consistent with previous observations that bulges im-
pose bends into RNA helical junctions.65 The natural
four-way junction strongly favors formation of the
docked complex, leading to an equilibrium in which
95% of the molecules are docked (	Gdock  1.7
kcal/mol). The four-way junction also compensates
for the loss of specific loop A-loop B interactions; a
G1A substitution or collapsing internal loops A and
B into Watson–Crick base-paired helices still leads to
39 and 35% docking, respectively. In fact, 23%
docked complex can even be detected in the absence
of substrate. In contrast, a perfect three-way junction
is found to lead to only 39% docked complex (	Gdock
 0.25 kcal/mol).25
Under physiologic conditions (1 mM Mg2), the
relative enhancement of hairpin ribozyme docking by
the four-way junction is still more dramatic. Here, the
FIGURE 3 Top, revealing the equilibrium between the extended and docked conformers of the
hairpin ribozyme by tr-FRET. For these studies, a noncleavable substrate analog is employed,
indicated by the crossed-out arrow. Middle, the donor decay data (black line) can only be fit
assuming lifetime contributions from two Gaussian donor–acceptor distance distributions, revealing
the presence of both extended (green contribution) and docked conformers (red contribution).
Bottom, the relative abundance of these isomers is directly obtained from the analysis and is
reflected in the relative peak areas of the corresponding distance distributions. Conditions: 50 mM
Tris HCl, pH 7.5, 12 mM MgCl2, at 17.8°C. Adapted from Ref. 25.
In the Fluorescent Spotlight 231
two-way junction yields only 8% docked complex,
while the four-way junction is characterized by more
than 90% docked conformation. Similar for the tem-
perature dependence: The four-way junction favors
docking at significantly higher temperatures than does
the two-way junction.25 This higher tertiary structure
stability of the naturally occurring four-way junction
hairpin ribozyme is the result of a lower entropic cost
of docking,66 and may play an important role for
folding and function of the ribozyme in vivo.
Re-ligation of previously cleaved RNA is an im-
portant step in rolling-circle replication of satellite
RNA in vivo, and requires assembly of a ternary
ribozyme–product complex for trans reactions in
vitro. In the presence of saturating concentrations of
nonligatable cleavage product analogs, tr-FRET re-
veals the global structures of the extended and docked
conformations and their equilibrium position to be
virtually identical to those in the presence of sub-
strate.25 This observation indicates that neither the
global structure nor the thermodynamic stability of
the docked conformation change significantly upon
cleavage, explaining the easy reversibility of cleav-
age.
In summary, our results prove tr-FRET to be an
elegant tool to study the free energy landscape asso-
ciated with folding of the hairpin ribozyme from a
defined intermediate to a native conformer. The flex-
ibility of the molecule is revealed and the measured
intramolecular distances may serve as constraints in
molecular modeling of the underlying global RNA
architecture.35 However, the large-scale conforma-
tional changes observed by FRET presumably are
accompanied by local structural changes. To study
their kinetics, a fluorescence probe sensitive to local
structural rearrangements is desirable. We found
2-aminopurine to provide for such a probe.
Local Structural Dynamics in the
Catalytic Core is Observed by
2-Aminopurine Fluorescence
The adenosine analog 2-aminopurine (AP) is a
strongly fluorescent base (excitation: 320 nm; emis-
sion: 360 nm; quantum yield: 68%) and can be selec-
tively excited in the presence of the naturally occur-
ring nucleobases, which maximally absorb around
260 nm.58,67 AP (ribo)nucleotide can be directly in-
corporated into a synthetic RNA chain, where it base
pairs with uracil and is very sensitive to local –
stacking interactions with surrounding nucleobases.
Stacking interactions with the natural nucleobases
generally quench the AP fluorescence,68 making it a
good probe of changes in those local interactions. To
monitor structural changes in the catalytic core of the
hairpin ribozyme, we have incorporated commercially
available 2-O-methylated AP ribonucleotide into po-
sitions 1, 1, or 2 of noncleavable substrate an-
alog S(dA-1), and monitored temporal changes in AP
steady-state fluorescence upon addition of a threefold
excess of ribozyme under standard conditions.63 Fig-
ure 4 illustrates our results. A G1AP mutant sub-
strate analog does not lead to any fluorescence
change, as this modification interferes with both dock-
ing and cleavage activity of the hairpin ribozyme,
similar to the G1A mutation (see section on domain
docking above). The A-1AP mutant substrate analog
shows a slight fluorescence decrease upon docking of
its ribozyme–substrate complex. By far the most sig-
nificant fluorescence change is observed upon dock-
ing of the U2AP substrate analog, in which case the
fluorescence increases more than two-fold, consistent
with substantial unstacking of the AP base. The ki-
netics of this local unstacking event is biphasic and
yields very similar rate constants as global docking of
this ribozyme–substrate analog complex when ob-
served by ss-FRET (Figure 4). This observation sug-
gests that global domain docking, as observed by
ss-FRET, is coupled to a local structural rearrange-
ment around position 2, as detected by AP fluores-
cence.
To further test whether AP2 unstacking and do-
main docking are directly linked, we have studied the
kinetics of the AP2 fluorescence change over a wide
range of Mg2 concentrations from 2 to 200 mM.63
Throughout this range, the fast-phase rate constant
increases with the Mg2 concentration and matches
that for global domain docking, suggesting that AP2
unstacking is the results of an induced fit between
substrate and ribozyme upon domain docking. This
provides direct evidence for quasi-hierarchical folding
of the hairpin ribozyme.21 The slow-phase rate con-
stant is Mg2 independent, possibly an indication that
the associated process may not be electrostatically
driven, unlike domain docking.
What precisely is the conformational rearrange-
ment that AP undergoes in position 2? AP fluores-
cence has a number of properties that can be used to
approach this question. Previously, it has been shown
that AP incorporated into a nucleic acid chain exhibits
four distinct fluorescence lifetimes that represent dif-
ferent base-stacking states;69 the longest lifetime, typ-
ically around 10 ns and yielding the highest steady-
state fluorescence signal, is indicative of a completely
unstacked base; the shortest lifetime (typically 50–90
ps) reflects a strongly stacked and quenched AP; and
the two intermediate lifetimes represent bases in the
population with partial stacking interactions. We find
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that the steady-state fluorescence increase observed
for the U2AP substrate analog is due to a substantial
fractional increase of the longest lifetime compo-
nent,63 further corroborating the notion that AP in
position 2 unstacks upon domain docking.
The fluorescence anisotropy decay of AP directly
reports on the motion of the base. The decay can be
caused by both local rotation of the base, which
occurs on the subnanosecond time scale, and overall
rotational diffusion of the complex in which the base
is incorporated, typically of a nanosecond time
scale.69 We therefore have compared the fluorescence
anisotropy decay of the U2AP mutant ribozyme–
substrate analog complex in the absence and presence
of Mg2 (i.e., before and after docking, respectively)
and have found that a fast-decay component of 420 ps
is lost upon domain docking.63 We therefore conclude
that the local motion of AP in position 2 becomes
restricted upon domain docking, so that its fluores-
cence anisotropy can only decay through the slow
overall rotational diffusion pathway.
How can these observations be explained in the
context of the recent crystal structure of the hairpin
ribozyme?37 Figure 1b shows details of the catalytic
core structure. As discussed above, the G1:C25
interaction is a crucial anchor point between the two
domains. It is possible only if G1 flips out of do-
main A and docks into a highly complementary bind-
ing pocket in the minor (shallow) groove of domain B
(Figure 1a). This conformational rearrangement leads
to complete unstacking of the 2 position nucleobase
from G1 (Figure 1b), explaining the observed
steady-state and time-resolved fluorescence changes
when this position is occupied with AP. Our data
therefore demonstrate that G1 flipping and domain
docking occur concomitantly, providing direct evi-
FIGURE 4 Analysis of the local structural change involving substrate position 2 of the hairpin
ribozyme under standard conditions (50 mM Tris HCl, pH 7.5, 12 mM MgCl2, at 25°C). (a) Change
of AP steady-state fluorescence upon docking. After formation of the ribozyme–substrate complex
(containing noncleavable substrate analogs with AP in either the 1, 1, or 2 position), the
relative change in AP fluorescence is observed; only the U2AP substrate leads to a significant
change that is best fit to a double-exponential growth function with the indicated rate constants (with
errors from comparing three independent determinations) and relative amplitudes. Dashed line,
contribution of the fast-phase component alone. (b) Analysis of the docking kinetics of U2AP
mutant ribozyme–substrate complex by ss-FRET. After formation of the ribozyme–substrate com-
plex (containing noncleavable substrate analog) under standard conditions, the relative FRET
efficiency between the domain terminal fluorophore pair increases as a result of domain docking.
The data are best fit to a double-exponential growth function (solid line)24 with the indicated rate
constants (with errors from comparing three independent determinations) and relative amplitudes.
Dashed line, contribution of the fast-phase component alone. Adapted from Ref. 63.
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dence for an induced fit of the two RNA domains
when engaging in a functional complex, consistent
with uv cross-linking results.70
The final question we have to address is why
cleavage of substrates mutated at position 2 is
slower than that of the U2 wild-type substrate. U2
is preferred, yet not absolutely required for cleavage,
as all mutants (including modification to an abasic
site) still result in significant cleavage activity.63 In
the crystal structure, U2 points away from the
cleavage site (Figure 1b), making a single hydrogen
bond with G8, which has been implicated in acting
as a general base (or possibly acid) catalyst.64 Hence,
it is unlikely that U2 plays a direct role in reaction
chemistry, and its mutation most likely interferes with
proper positioning of G8. Our tr-FRET data suggest
that U2 substitutions stabilize a docked conforma-
tion; our AP fluorescence data suggest that the AP2
base unstacks from G1, as seen for U2 in the
crystal structure, and becomes restricted in its struc-
tural dynamics. tr-FRET and hydroxyl-radical foot-
printing data indicate that the docked conformer of the
mutant ribozyme–substrate complexes has the same
interdomain distance and specific solvent-inaccessible
core as that of the wild-type complex, i.e., it is native-
like.63 A plausible explanation for these observations
is that bases substituting U2 establish additional
interactions that stabilize a native-like conformation,
yet have to be broken for the complex to proceed to
the chemical transition state. Only a uracil in position
2 makes the correct contacts (for example to G8)
and/or avoids incorrect contacts that lead to a kinetic
trap. Consistent with this model, the additional stabi-
lization energy measured by tr-FRET for the docked
conformer of a U2G mutant substrate is of the same
magnitude as its additional transition state enthalpy
(0.5 kcal/mol).63
THE HDV RIBOZYME
HDV is a small satellite of the hepatitis B virus
(HBV). HDV is an infectious human pathogen that,
upon coinfection with HBV, results in intensification
of disease symptoms associated with hepatitis, such as
liver cirrhosis.71 Both the circular HDV RNA genome
and its complementary antigenome contain the same
cis-cleaving, 85 nucleotide catalytic RNA motif.
The sequences of these two forms of the HDV ri-
bozyme are 75% identical, and they share a second-
ary structure comprising the five helices P1, P1.1, P2,
P3, and P4, intertwined in a nested double pseudoknot
(Figure 5a).71,72 The HDV ribozyme is the only
known catalytic RNA associated with an animal virus,
yet it has the same function in double-rolling circle
replication of HDV RNA as the other small ribozymes
isolated from satellite RNAs of plants and fungi.
Both cis- and trans-cleaving derivatives of the
HDV ribozyme have been used to study the interplay
of structure and function in this catalytic RNA. For
example, cross-linking studies on a trans-acting ver-
sion showed that introduction of a photoreactive azi-
dophenacyl group at the cleavage site results in spe-
cific cross-links to the joining sequence between P4
and P2 (J4/2), and to the 3 sides of P3 and its closing
loop L3.73 These results correlate well with hydroxyl
radical footprinting data, which indicate that these
regions become solvent inaccessible when the HDV
ribozyme is folded in the presence of millimolar
Mg2 concentrations.73 Taken together these data
suggest the formation of a compact tertiary structure
that places the cleavage site phosphate deep within an
active site cleft that is surrounded by nucleotides
previously found to be functionally important.72
The crystal structure of the 3 product of a cis-
acting form of the genomic ribozyme, engineered to
bind to the small RNA-binding U1A protein, has
provided a good platform to rationalize these and
other biochemical data.74 Its overall secondary struc-
ture and base-pair interactions are summarized in the
inset of Figure 5a, with details of the catalytic core in
Figure 5b. Recent studies have revealed that the HDV
ribozyme has the ability to cleave in the presence of
monovalent metal ions alone, albeit with significantly
reduced activity.46 This observation, as for the hairpin
ribozyme, implies that the RNA chain contains all
necessary components for cleavage and exactly posi-
tions them in the catalytic core for reaction chemistry
to occur. The crystal structure of the 3 product shows
the O2 and N3 of a specific cytosine, C75 (C76 in the
antigenomic form), within hydrogen-bonding distance
of the 5 leaving group, suggesting that this nucleo-
base may play an active role in catalysis.74 Indeed, a
C76A mutation in the antigenomic form results in pKa
changes of the self-cleavage reaction that are consis-
tent with this nucleotide acting as a general base
catalyst.75 However, the inverted pH dependence of
self-cleavage by the genomic ribozyme in the pres-
ence of monovalent metal ions supports a mechanism
in which C75/76 acts instead as a general acid cata-
lyst.46 Although the latter observation might alterna-
tively be explained by the pH susceptibility of a
three-nucleotide motif unique to the genomic se-
quence,76 there is little doubt that the HDV ribozyme,
like the other small ribozymes, is an example of the
growing number of catalytic RNAs in which an RNA
side chain actively contributes to transition state
chemistry.12,77,78 Studies of the folding pathway of
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FIGURE 5 Catalysis by the HDV ribozyme. (a) Schematic of the minimal reaction pathway of the
trans-acting HDV ribozyme as refined by our FRET studies. Reversible substrate binding and
formation of helix P1 causes the ribozyme complex to become slightly more compact; FRET (green
arrow) between a terminal donor (D) and acceptor (A) fluorophore pair increases (indicative of a
fluorophore distance decrease from 56 to 53 Å) and we observe a single red-shifted band on a FRET
gel-shift assay (shown below the schematic of each complex). After catalysis, the 5 product is
released (with no observable re-ligation) and the overall structure of the ribozyme–3 product
complex becomes significantly extended (to 68 Å) as evidenced by a decrease in FRET and a
green-shifted FRET gel-shift band. This ribozyme–3 product complex models the postcleavage
crystal structure74 (inset: two-dimensional representation of our construct with its 5 and 3 products
(5P, 3P), shown with a tertiary structure annotation according to Ref. 85 as expected from the
crystal structure; the colored nucleotides and wobble pair interaction are the ones detailed in (b).
Slow 3 product release allows the ribozyme to regenerate and undergo another catalytic cycle. The
indicated rate and equilibrium constants were measured in 40 mM Tris HCl, pH 7.5, 11 mM MgCl2,
at 25°C. Adapted from Ref.80. (b) Details of the catalytic core in the postcleavage structure. G1
is held in place by a two-hydrogen-bond wobble interaction (dashed tubes) with U37 so that the
cleavage site (arrow) becomes exposed to C75, the potential general acid or base catalyst. U27, a
unique insert found in loop L3 of the crystallized genomic form of the HDV ribozyme (not present
in our original construct shown in (a), unstacks from helix P3 and the adjacent C26 (green ribbon,
backbone). This figure was generated using the 3 product crystal structure74 and Swiss-PdbViewer
3.7.86
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the HDV ribozyme will reveal how this catalytic RNA
is able to position the essential reaction components to
accomplish site-specific chemistry.
Up to now, in the absence of information on any
conformational changes, the prevalent assumption has
been that the precursor, transition state, and cleaved
structures are all alike.74,79 To test this assumption,
we have applied our array of ss-FRET, tr-FRET, and
AP fluorescence assays to probe for global and local
structural rearrangements on the reaction pathway of
the trans-acting HDV ribozyme. We have found ev-
idence for surprisingly large conformational changes
that are summarized in Figure 5a and reviewed below.
A Global Structural Transition Upon
Cleavage of the trans-Acting HDV
Ribozyme is Revealed
by Steady-State FRET
To allow for attachment of fluorescein and tetrameth-
ylrhodamine as donor–acceptor pair to the ends of
helices P4 and P2, respectively, we have separated the
HDV ribozyme into three synthetically accessible
RNA strands, two ribozyme strands, and an external
substrate, as indicated in Figure 5a. The RNA se-
quences are a hybrid between the genomic and anti-
genomic forms of the HDV ribozyme, and were de-
rived after screening a number of variants for optimal
activity. By annealing at least a twofold excess of the
unlabeled strand to the labeled one, a catalytically
active ribozyme is formed that cleaves substrate S3 at
a rate constant of 0.68 min1 under standard condi-
tions (40 mM Tris HCl, pH 7.5, 11 mM MgCl2, at
25°C). This catalytic activity compares well with pre-
viously characterized trans-acting HDV ribozymes.
Together with similar metal ion, temperature, and pH
dependencies, this establishes our three-strand ri-
bozyme as a suitable model system to study folding of
the HDV ribozyme into a functional structure.80
To investigate conformational changes upon sub-
strate binding, we employ a noncleavable S3 substrate
analog, ncS3, with a 2O-methyl modification at the
cleavage site to block reaction chemistry. When this
substrate is added to the assembled ribozyme in sat-
urating excess, a 9% increase in relative FRET effi-
ciency is observed as the result of precursor complex
formation (Figure 6a). The pseudo-first order rate
constant for this increase is linearly dependent on the
excess concentration of ncS3, indicating that the ob-
served FRET increase is a direct result of substrate
binding. From this dependence we are able to extract
a second-order substrate binding rate constant kon of
7.8 
 106M1min1, within threefold of a value
previously measured for a related HDV ribozyme–
substrate complex.81 When instead the cleavable sub-
strate S3 is added, we observe a slight initial increase
and subsequent significant decrease by 26% in rela-
tive FRET efficiency (Figure 6a). The rate constant of
the latter FRET decrease is similar (0.50 min1) to the
cleavage rate constant obtained using radioactive as-
says.80 These observations are consistent with the
notions that (1) the substrate (precursor) complex is
slightly more compact than the free ribozyme, leading
to a slight FRET increase upon substrate binding; and
(2) that the complex becomes significantly extended
upon cleavage and product complex formation, yield-
ing a strong FRET decrease.
To further test this hypothesis we directly initiated
the formation of the product complex by adding only
the 3 segment of the substrate (5-GGGUCGG-3,
termed 3P, Figure 5a) to the ribozyme. It has been
shown previously that this 3 segment stays bound to
the ribozyme after cleavage, while the 5 segment
rapidly dissociates.81 Indeed, upon addition of 3P to
the ribozyme the relative FRET efficiency rapidly
decreases by 33%, indicating the formation of an
extended product complex (Figure 6a). A FRET de-
crease by 33% upon direct formation of the product
complex compared to 26% upon binding and cleavage
of substrate is consistent with the fact that typically
77% of substrate is cleaved and converted to prod-
uct complex under these conditions.80
We also have used 3P as a chase to measure the
dissociation rate constant of ncS3. To this end, we
first form the ribozyme–ncS3 complex, then add a
micromolar excess of 3P. We observe a single-expo-
nential FRET decrease. Its rate constant koff  0.34
min1 is independent of the concentration of 3P,
indicating that our chase concentration is sufficient,
and that active displacement (i.e., a promotion of
substrate dissociation) by the chase does not take
place.82 This substrate dissociation rate constant is
within fourfold of a previously reported value for
another trans-acting HDV ribozyme,81 and together
with the substrate binding rate constant kon, defines
the equilibrium dissociation constant KD  koff/kon as
44 nM. Conversely, the 3 product cannot be chased
off its complex, even when utilizing up to a 5 M
excess of ncS3 as chase, indicating its significantly
higher binding affinity, as previously observed.81
One feature of ss-FRET measurements in bulk
solution is that they average over all molecule con-
formations present. To test for the homogeneity of our
preparations and further confirm that the ribozyme–
substrate and –product complexes are indeed structur-
ally distinct, we have developed a FRET gel mobility
assay similar to one used to characterize protein–
nucleic acid interactions.83 Ribozyme alone and in
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complex with S3, ncS3, and 3’P is electrophoresed on
a nondenaturing polyacrylamide gel. The gel is then
scanned with 488 nm light from a laser and the
fluorescence emission F is observed at two different
wavelength ranges, around 530 nm for the fluorescein
donor and 610 nm for the tetramethylrhodamine
acceptor. A relative FRET efficiency for a band in the
gel is calculated as Facceptor/Fdonor, and, defining
Fdonor as green and Facceptor as red, the image in
Figure 6b was generated.80 We find that the free
ribozyme (Rz) as well as its complexes with 3P and
ncS3 migrate as homogeneous single bands, with any
alternate bands contributing less than 15% of the
intensity of the major ones. Lane 1, loaded with the
free ribozyme, shows a band with intermediate accep-
tor-to-donor (FRET) ratio (Figure 6b, lower panel),
consistent with our solution measurements. Its band
comigrates with the ribozyme–3P complex in lane 2,
which shows a decreased FRET ratio (or “green-
shifted”, i.e., donor-fluorescence dominated band).
Lane 4, loaded with the ribozyme–ncS3 complex,
shows a band with increased FRET ratio (“red-shift-
ed”) and lower mobility, also consistent with the
solution measurements. These findings further sup-
port the existence of structurally distinct pre- and
postcleavage ribozyme complexes.
Lane 3, loaded with the ribozyme-cleavable sub-
strate complex (RzS3), shows a band identical in
color and mobility to the one in lane 2 (Figure 6b),
suggesting that the substrate has largely been cleaved
and converted into ribozyme-bound 3 product. The
result is similar when the ribozyme is first run into the
gel for 2 h, followed by the faster migrating substrate
so that the ribozyme–substrate complex can only form
and cleave in the gel (data not shown). These obser-
vations provide evidence that cleavage of substrate S3
FIGURE 6 Steady-state FRET studies using 50 nM of fluorescein–tetramethylrhodamine labeled
trans-acting HDV ribozyme in 40 mM Tris HCl pH 7.5, 11 mM MgCl2, 25 mM DTT, at 25°C. (a)
Change over time in the relative FRET efficiency of the doubly labeled ribozyme upon addition of
250 nM noncleavable substrate analog (ncS3), cleavable substrate (S3), or 3 product (3P), as
indicated. Inset: The data set for S3, after a short initial increase, gives an exponential decrease that
pertains to substrate cleavage (solid line; rate constant: 0.50 min1). (b) Nondenaturing polyacryl-
amide gel electrophoresis of fluorescein-tetramethylrhodamine doubly labeled complexes. The free
ribozyme (Rz) comigrates with the ribozyme–3 product complex (Rz3P, upper panel), but can
be distinguished by its ratio of acceptor:donor fluorescence (lower panel; error bars are derived from
three gel runs). The ribozyme–substrate complex (RzS3) undergoes catalysis and is observed as
the ribozyme–3 product complex, while the ribozyme–noncleavable substrate analog complex
(RzncS3) stays intact, migrating slower with a higher acceptor:donor fluorescence ratio. Adapted
from Ref. 80.
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occurs within the native gel—hence, our ribozyme–
substrate complex is catalytically active.
Our results demonstrate conformational dynamics
of the trans-acting HDV ribozyme along its reaction
pathway (Figure 5a). Upon substrate binding a slight
structural compaction is observed. This is followed by
a substantial extension as cleavage occurs. The latter
conformational change is related to the catalytic RNA
achieving its transition state, which begs the question
of whether the transition state structure resembles
more that of the precursor or the ribozyme–3 product
complex.
There is strong evidence from pH titration exper-
iments that C75/76 deprotonates the 2 hydroxyl nu-
cleophile75 and/or protonates the 5 oxyanion leaving
group in the rate-limiting step (i.e., in the transition
state) of phosphodiester transfer.46,76,77 In the 3 prod-
uct crystal structure, O2 and N3 of C75/76 are within
hydrogen-bonding distance to the 5 OH leaving
group.12,74 Therefore, it is plausible that a C75/76-
5OH hydrogen bond, or a similar interaction, is also
present in the transition state, juxtaposing the catalytic
base and the scissile phosphate. Given that the sub-
strate and product complexes are structurally distinct,
as directly observed here by ss-FRET, we have pro-
posed that the transition state in HDV ribozyme ca-
talysis is closer in structure to, although not necessar-
ily identical with, the product complex.80 We specu-
late that our capture of significant structural change
along the reaction trajectory may present the struc-
tural basis of the recently described utilization of
intrinsic substrate binding energy to the overall cata-
lytic rate enhancement by the trans-acting HDV ri-
bozyme.84
Whereas ss-FRET has revealed the existence and
kinetics of global conformational changes of the HDV
ribozyme, tr-FRET allows for the extraction of abso-
lute donor–acceptor fluorophore distances, as dis-
cussed in the following.
The Global Geometries of Precursor and
Product Forms are Derived from
Time-Resolved FRET
While our analyses of acceptor-to-donor fluorescence
ratios reveal qualitative changes in fluorophore dis-
tance, we also sought to quantify the underlying RNA
structural changes. We therefore have analyzed the
time-resolved donor (fluorescein) decay curves for the
ribozyme alone (Rz), the ribozyme–noncleavable sub-
strate analog complex (RzncS3), and the ri-
bozyme–3 product complex (Rz3P), each of them
singly labeled with donor, as well as doubly labeled
with donor and acceptor. The decay curves of the
three donor-only labeled complexes virtually super-
impose and yield similar mean lifetimes of approxi-
mately 4 ns (Table I).80 The donor fluorescence de-
cays of all three donor–acceptor doubly labeled com-
plexes are faster, indicative of FRET between donor
and acceptor. The anisotropies of the fluorophores in
all complexes are low and only slightly vary between
the different complexes (Table I), suggesting that both
donor and acceptor can freely rotate. Under this as-
sumption and using Förster theory, the fluorophore
distance distributions are analyzed as described in the
section on global geometry and equilibrium position,
yielding mean donor–acceptor distances of 56 Å (full-
width-at-half-maximum, fwhm: 25 Å) for the ri-
bozyme; 53 Å (fwhm: 19 Å) for the ribozyme–ncS3
complex; and 68 Å (fwhm: 27 Å) for the ribozyme–
3P complex (Table I). In all three cases, a single
distance distribution fits the decay data well, as
judged by the residuals and the reduced 2 values
(1.5, Table I); introducing a second distance distri-
bution does not improve the fits, indicating a high
structural homogeneity of our RNA preparations.
These time-resolved FRET data directly support our
steady-state fluorescence measurements (see section
immediately above) in that the substrate complex is
slightly more compact (by 3Å) than the free ri-
Table I Fluorescence Properties of Fluorescein (Donor) and Tetramethylrhodamine (Acceptor) Labeled Ribozyme
Constructsa
Parameter Rz RzncS3 Rz3P
Mean donor lifetime without acceptor (ns) 4.11  0.05 4.18  0.05 3.93  0.05
Mean donor–acceptor distance (Å) 56  1 53  1 68  1
fwhm (Å) 25  1 19  1 27  1
2 1.36 1.43 1.48
Anisotropy donor 0.013  0.003 0.013  0.003 0.013  0.003
Anisotropy acceptor 0.021  0.003 0.024  0.003 0.022  0.003
a Values are from Ref. 80; fwhm, full-width-at-half-maximum; 2, reduced chi-square.
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bozyme, yet becomes significantly extended (by 15
Å) upon cleavage and product complex formation
(Figure 5a).80 Interestingly, the full-width-at-half-
maximum of these complexes, which is a measure of
their structural flexibility, suggests that a relatively
rigid structure is acquired prior to cleavage whereas
the postcleavage complex adopts a more flexible con-
formation.
The fluorophore distance measured for our ri-
bozyme–3P complex (68 Å) can directly be com-
pared to an analogous distance of 74 Å between
helices P2 and P4 in the crystal structure of the
self-cleaved genomic form of the HDV ribozyme.74
Considering the fact that the crystallized construct
contains an artificial U1A-protein binding loop to
close helix P4, these distances are in good agreement.
Our measurements for the free ribozyme and the
substrate-bound precursor lack such values from high
resolution structures to compare with. However, our
discovery of significant global conformational change
along the HDV ribozyme reaction pathway (Figure
5a)80 raises the question of whether local structural
transitions also occur. FRET does not allow us to
directly detect such transitions since the donor–accep-
tor probes are positioned far from the catalytic core.
Therefore, we have begun to utilize 2-aminopurine as
a local fluorescent probe to provide such information.
Local Structural Dynamics upon
Cleavage is Observed by AP
Fluorescence
To complement our FRET measurements that reveal
global conformational changes of the HDV ribozyme,
we have started to examine localized conformational
transitions by fluorescence quenching of AP ribonu-
cleotide inserted into position 27 of our three-strand
ribozyme construct (see also section on local struc-
tural dynamics above). This choice is based on the
proximity of position 27 to the catalytic core of the
genomic form of the HDV ribozyme (Figure 5b) and
on the fact that U27 in the genomic form is tolerated
without loss of cleavage activity compared to the
antigenomic form that lacks this insertion.72
Similar to our ss-FRET assays (see section on
global structural transition above), AP27 fluorescence
changes are monitored over time upon addition of
saturating concentrations of the noncleavable sub-
strate analog S3 (ncS3), cleavable substrate (S3), or 3
product (3P) (Figure 7). Our results are consistent
with the findings from our ss-FRET experiments in
that they reveal not only globally but also locally
distinct pre- and postcleavage conformations. In par-
ticular, a slight decrease in AP fluorescence is ob-
served upon binding of ncS3, indicating formation or
stabilization of local stacking interactions between
AP27 and neighboring nucleobases in the complex.
By contrast, a significant increase in AP fluorescence
occurs upon binding of 3P, indicative of AP unstack-
ing (see section on local structural dynamics above).
This observation is consistent with the 3 product
crystal structure in which position 27 is extruded from
the stack of helix P3 (Figure 5b).74 Finally, when
cleavable substrate S3 is added to the ribozyme, a
subtle decrease is followed by a substantial increase in
AP fluorescence. This pattern suggests that the sub-
strate binds and is subsequently cleaved, leading to
initial stacking in the ribozyme–substrate and un-
stacking in the ribozyme–3 product complex. Our
data demonstrate that local structural rearrangements
near the catalytic core occur upon substrate binding
and cleavage.
It is difficult to model the substrate sequence 5 of
the cleavage site extending out of the catalytic core of
the postcleavage crystal structure without sterical
clash. This raises the idea that the 5 extension may be
involved in the local structural rearrangement re-
ported by AP fluorescence. One of several possible
explanations for the structural difference between the
substrate and product complexes then is that helix
P1.1, which forms the bottom of the catalytic cleft, is
absent in the substrate complex to accommodate the
substrate 5 extension, as suggested in Figure 5a. AP
as a fluorescent probe reveals such subtle localized
dynamics in the HDV ribozyme that cannot be de-
tected by FRET.
The slow time course of S3 substrate cleavage in
Figure 7 reveals that insertion of AP in position 27 of
the HDV ribozyme leads to a 170-fold reduced cleav-
age rate. Ideally, a modification within the ribozyme
used to report on conformational changes should not
so drastically affect the rate of cleavage. In this par-
ticular case, AP27 probably forms a Watson–Crick
base pair with U20; such a base pair is expected to
stack on helix P3 in place of the G25:U20 trans-
Watson–Crick base pair shown in Figure 5a. This
local structure would be consistent with the strong
fluorescence quenching observed in the AP27 modi-
fied ribozyme–substrate complex. Apparently, AP27
stacking interactions have to be broken to proceed to
catalysis and formation of the ribozyme–3 product
complex, in which AP27 is strongly unquenched and
hence unstacked. The necessary breaking of favorable
AP27 stacking (and possibly hydrogen-bonding) in-
teractions would explain the slower cleavage rate
upon introduction of this modification, an example for
a kinetic RNA folding trap. We are currently explor-
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ing other modification sites to monitor local structural
transitions in the HDV ribozyme.
CONCLUSIONS
We have made use of fluorescence resonance energy
transfer and 2-aminopurine quenching to highlight
global and local conformational changes, respec-
tively, in small catalytic RNAs such as the hairpin and
HDV ribozymes. These RNA enzymes precisely po-
sition reaction components for site-specific organic
chemistry, which requires folding into a particular
three-dimensional structure. Both their folding and
catalytic activity make use of the dynamic nature of
an RNA structure, which typically is characterized by
a rugged folding free energy landscape. Fluorescence
techniques explore these landscapes and provide ki-
netic and thermodynamic information. Further devel-
opments in RNA synthesis and labeling and fluo-
rescence spectroscopic equipment (including that
for single-molecule experiments) will broaden the
application of the concepts described herein to other
RNAs. The more RNA systems are studied this way,
the better we will understand the physicochemical
principles that govern the function of this ubiquitous
biopolymer.
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